BioLineRx Presents Positive Safety and Efficacy Results for Novel Stem-Cell Mobilization Treatment at European Hematology Association Conference

TEL AVIV, Israel, Jun 15, 2015 (BUSINESS WIRE) — BioLineRx Ltd. BLRX, -1.04% (tase:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today the presentation …

[Read the full article here]

Comments are closed.